SEC Form 4 · accession 0001209191-18-045084
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey M. Curtis
Officer — EVP, Corporate Affairs, CCO
Period of report
Aug 1, 2018
Accepted (ET)
Aug 2, 2018 · 6:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Aug 1, 2018 | M | 30,000 | — | A | 47,461 | D | |
| Ordinary Shares | Aug 1, 2018 | F | 8,790 | $17.72 | D | 38,671 | D | |
| Ordinary Shares | holding | — | — | — | 420 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Aug 1, 2018 | M | 30,000 | D | — | — | Ordinary shares | 30,000 | 30,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2Includes 645 ordinary shares of the Issuer acquired by the reporting person on June 1, 2018 pursuant to an employee stock purchase program.
- F350% of the shares subject to the restricted stock units shall vest on each of August 1, 2018 and August 1, 2019.